NCT03302897View on ClinicalTrials.gov

Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

March 5, 2019

Study Completion Date

March 5, 2019

Conditions
Leprosy
Interventions
BIOLOGICAL

LEP-F1 + GLA-SE

Investigational vaccine

Trial Locations (1)

53704

Covance Clinical Research Unit, Madison

All Listed Sponsors
collaborator

American Leprosy Missions

UNKNOWN

lead

Access to Advanced Health Institute (AAHI)

OTHER

NCT03302897 - Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter